HomeWAVE • CVE
add
Waverley Pharma Inc
Previous close
$0.020
Year range
$0.010 - $0.035
Market cap
1.08M CAD
Avg Volume
16.72K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 391.34K | — |
Operating expense | 161.90K | -28.26% |
Net income | -36.08K | 86.34% |
Net profit margin | -9.22 | — |
Earnings per share | — | — |
EBITDA | 1.77K | 101.22% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 143.62K | 165.42% |
Total assets | 1.52M | 81.17% |
Total liabilities | 3.59M | 60.32% |
Total equity | -2.07M | — |
Shares outstanding | 54.00M | — |
Price to book | -0.50 | — |
Return on assets | -2.75% | — |
Return on capital | -4.76% | — |
Cash Flow
Net change in cash
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -36.08K | 86.34% |
Cash from operations | -161.55K | -44.04% |
Cash from investing | 45.40K | — |
Cash from financing | 23.84K | -78.95% |
Net change in cash | -92.31K | -8,538.12% |
Free cash flow | -412.78K | -1,007.44% |
About
Founded
2014
Headquarters
Website
